Device Trial Radar · NCT00069537
Continuous Glucose Monitors for Children With Diabetes Mellitus
Last checked: Nov 20, 2026Latest source record: Sep 5, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
90
Actual
Start
May 2002
Primary completion
Not stated
Study completion Nov 2002
Sponsor
- Lead sponsor
- Jaeb Center for Health ResearchAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- First posted
- Sep 30, 2003
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 year, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Good control of blood glucose levels is important in preventing complications from diabetes. This study assessed the accuracy and reliability of two FDA-approved continuous glucose monitors, the Continuous Glucose Monitoring System (CGMS) and the GlucoWatch G2 Biographer (GW2B), in children with type 1 diabetes mellitus (T1DM).
Conditions
- Diabetes Mellitus, Insulin-Dependent
Interventions
The GlucoWatch® G2™ Biographer (GW2B)Device
The Continuous Glucose Monitoring System (CGMS™)Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Accuracy of the GlucoWatch G2 Biographer and CGMS
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Division of Pediatric Endocrinology and Diabetes, Stanford University
Stanford, California
Barbara Davis Center for Childhood Diabetes, University of Colorado
Denver, Colorado
Department of Pediatrics, Yale University School of Medicine
New Haven, Connecticut
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.